Clinical Foundation

Why monofilaments?

The 5.07 monofilament is the most validated, widely adopted tool in diabetic foot screening. Here is the clinical case for why it matters, and why calibration is everything.

34M
Americans living with diabetes
50%
of diabetic patients have peripheral neuropathy
85%
of diabetic amputations are preventable with screening
>50%
of non-traumatic amputations caused by diabetic neuropathy

The Problem

Diabetic neuropathy is silent, until it isn't.

Peripheral neuropathy, the progressive loss of sensation in the extremities, affects roughly half of all diabetic patients. The danger is that patients often cannot feel it happening. By the time symptoms are obvious, the window for prevention may have already closed.

Without protective sensation, minor injuries, a blister, a cut, a pressure point from a shoe, go unnoticed and unaddressed. In a patient with compromised circulation, these injuries can escalate rapidly: infection, ulceration, and in severe cases, amputation.

Annual foot screening with a monofilament is the standard-of-care response to this risk. It takes under two minutes to administer and can identify patients who have lost protective sensation before they experience a serious complication.

Every 17s
A new diabetes diagnosis occurs somewhere in the world.
1 in 4
Diabetic patients will develop a foot ulcer in their lifetime.
5 years
The average survival rate after a lower-limb amputation is under 5 years.

The Tool

How a monofilament works.

The Semmes-Weinstein monofilament test uses a single filament made of a proprietary polymer to apply a controlled, reproducible force to specific sites on the plantar surface of the foot. When the filament bends under pressure, the force it delivers depends on the filament's diameter, stiffness and length.

The 5.07 monofilament, the standard for diabetic screening, is calibrated to deliver a 10 gram force range, ±1.5 g, at the point of flexion. This threshold was established through decades of clinical research as the minimum sensation required for protective awareness. Patients who cannot detect the 10-gram stimulus have lost protective sensation and are classified as high risk for ulceration.

The test is simple to administer: the clinician touches the filament to the four test sites on each foot while the patient, eyes closed, reports whether they feel contact. Results are recorded by site. A single missed site is clinically significant.

1
Patient closes their eyes
No visual cues. The test measures sensory perception, not anticipation.
2
Clinician applies the filament
Pressed to the skin until the filament bends, delivering a 10 gram force range, ±1.5 g.
3
Patient responds "yes" or nothing
Each site marked positive or negative. Tested at four plantar sites on each foot.
4
Results inform risk classification
Any missed site indicates LOPS. Patient is flagged for elevated monitoring and care.

Why Calibration Matters

An uncalibrated monofilament isn't a medical device. It's a guess.

The diagnostic value of the monofilament test depends entirely on the instrument delivering a consistent 10 gram force range, ±1.5 g. A filament that has degraded through repeated use, improper storage, or inconsistent manufacturing may deliver 7 grams, or 12, or something in between, none of which corresponds to the validated clinical threshold.

Studies have shown that monofilaments lose stiffness with repeated use. A filament used on multiple patients, or used more than once on the same patient, can no longer be assumed to deliver the 10 gram force range, ±1.5 g. The test becomes unreliable. A patient who fails to detect a degraded filament may be classified as normal when they are not, or vice versa.

This is why the FDA guideline specifies monofilaments as single-use devices. And it is why the manufacturing process behind the filament matters as much as the protocol used to administer it.

FDA Guideline

"Monofilaments are single-use devices. Each filament guarantees the 10-gram force range for one test. Reuse introduces force variability that invalidates the clinical result."

Why Medical Monofilament

The only 510(k)-cleared monofilament manufacturer in the United States.

FDA 510(k) Cleared

The only monofilament manufacturer in the U.S. with FDA 510(k) clearance. Our device has been reviewed for safety and effectiveness against a predicate device. Many competitors have never undergone this review. Monofilaments are FDA Class I, single-use devices, and single use prevents cross-contamination between patients.

Patented Precision Process

Our automated manufacturing line uses proprietary inline sensors and daily gram-scale calibration to verify every filament before it leaves the facility. Human variability is removed from the equation entirely.

Made in the U.S.A.

Every component manufactured in Plymouth, Massachusetts. Domestic manufacturing means tighter quality control, shorter supply chains, and accountability at every step.

27+ Years of Clinical Trust

Founded in 1999 and continuously manufacturing since. Our products are used in home care, podiatric and primary care offices, hospitals, diabetes clinics, and government agencies including the VA and the Department of Defense. That track record is not an accident.

Ready to screen with confidence?

Shop our full line of 5.07 monofilaments, available in 7 handle styles and three pack sizes.